Imunon, Inc. - 8-K Filing

Imunon raised $10 million through a private placement with Streeterville Capital on June 3, 2026. The deal included 250 shares of Series A Preferred Stock ($10k/share), and two secured promissory notes totaling $7.72 million (A-1 Note: $2.72M at 8% interest; B Note: $5M at 5%). $5 million was deposited as cash collateral, with the remaining funds allocated for R&D, capital expenditures, and working capital. (Items: 1.01 is incorporated into this Item 2, 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year On June 1, 2026, the Company filed a certificate of designation of p)

SEC EDGAR ·

Tickers: $IMNN

Read the full article at SEC EDGAR

More Regulatory news